首页 > 最新文献

Experimental cell research最新文献

英文 中文
A semi-permeable insert culture model for the distal part of the nephron with human and mouse tubuloid epithelial cells. 使用人类和小鼠肾小管上皮细胞的肾小管远端半渗透插入培养模型。
IF 3.3 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2024-11-19 DOI: 10.1016/j.yexcr.2024.114342
E Dilmen, C J A Olde Hanhof, F A Yousef Yengej, C M E Ammerlaan, M B Rookmaaker, I Orhon, J Jansen, M C Verhaar, J G Hoenderop

Tubuloids are advanced in vitro models obtained from adult human or mouse kidney cells with great potential for modelling kidney function in health and disease. Here, we developed a polarized human and mouse tubuloid epithelium on cell culture inserts, namely Transwell™ filters, as a model of the distal nephron with an accessible apical and basolateral side that allow for characterization of epithelial properties such as leak-tightness and epithelial resistance. Tubuloids formed a leak-tight and confluent epithelium on Transwells™ and the human tubuloids were differentiated towards the distal part of the nephron. Differentiation induced a significant upregulation of mRNA and protein expression of crucial segment transporters/channels NKCC2 (thick ascending limb of the loop of Henle), NCC (distal convoluted tubule), AQP2 (connecting tubule and collecting duct) and Na+/K+-ATPase (all segments) in a polarized fashion. In conclusion, this study illustrates the potential of human and mouse tubuloid epithelium on Transwells™ for studies of tubuloid epithelium formation and tubuloid differentiation towards the distal nephron. This approach holds great promise for assisting future research towards kidney (patho)physiology and transport function.

肾小管是一种先进的体外模型,由成年人类或小鼠肾脏细胞获得,在模拟健康和疾病肾脏功能方面具有巨大潜力。在这里,我们在细胞培养插片(即 Transwell™ 过滤器)上开发了极化的人和小鼠肾小管上皮细胞,作为远端肾小球的模型,其顶端和基底侧均可触及,可用于表征上皮特性,如漏密性和上皮阻力。肾小管在 Transwells™ 上形成了一个密闭和汇合的上皮细胞,人类肾小管向肾小管远端分化。分化诱导关键节段转运体/通道 NKCC2(亨利环粗升支)、NCC(远曲小管)、AQP2(连接小管和集合管)和 Na+/K+-ATP 酶(所有节段)的 mRNA 和蛋白表达以极化方式显著上调。总之,这项研究说明了 Transwells™ 上的人和小鼠肾小管上皮在研究肾小管上皮形成和肾小管向远端肾小管分化方面的潜力。这种方法在协助未来的肾脏(病理)生理学和运输功能研究方面大有可为。
{"title":"A semi-permeable insert culture model for the distal part of the nephron with human and mouse tubuloid epithelial cells.","authors":"E Dilmen, C J A Olde Hanhof, F A Yousef Yengej, C M E Ammerlaan, M B Rookmaaker, I Orhon, J Jansen, M C Verhaar, J G Hoenderop","doi":"10.1016/j.yexcr.2024.114342","DOIUrl":"10.1016/j.yexcr.2024.114342","url":null,"abstract":"<p><p>Tubuloids are advanced in vitro models obtained from adult human or mouse kidney cells with great potential for modelling kidney function in health and disease. Here, we developed a polarized human and mouse tubuloid epithelium on cell culture inserts, namely Transwell™ filters, as a model of the distal nephron with an accessible apical and basolateral side that allow for characterization of epithelial properties such as leak-tightness and epithelial resistance. Tubuloids formed a leak-tight and confluent epithelium on Transwells™ and the human tubuloids were differentiated towards the distal part of the nephron. Differentiation induced a significant upregulation of mRNA and protein expression of crucial segment transporters/channels NKCC2 (thick ascending limb of the loop of Henle), NCC (distal convoluted tubule), AQP2 (connecting tubule and collecting duct) and Na<sup>+</sup>/K<sup>+</sup>-ATPase (all segments) in a polarized fashion. In conclusion, this study illustrates the potential of human and mouse tubuloid epithelium on Transwells™ for studies of tubuloid epithelium formation and tubuloid differentiation towards the distal nephron. This approach holds great promise for assisting future research towards kidney (patho)physiology and transport function.</p>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":" ","pages":"114342"},"PeriodicalIF":3.3,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seven Theorems of Joseph G. Gall. 约瑟夫-G-加尔的七个定理
IF 3.3 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2024-11-18 DOI: 10.1016/j.yexcr.2024.114343
Ji-Long Liu

On June 30, 2020, Professor Joseph Grafton Gall announced his retirement at 92. On August 13, 2020, Joe's former trainees and colleagues held a retirement celebration online to celebrate Joe's "Remarkable Career with Astonishing Discoveries", covering Joe's nearly 70 years of education and research. As a representative of Joe's trainees in the 2000s, I gave a speech titled "Seven Theorems of Joe". On September 12, 2024, Joe passed away peacefully, at 96. In memoriam, here I expand and update my previous speech and explain the "Seven Theorems of Joseph G. Gall", a scientists' scientist.

2020 年 6 月 30 日,约瑟夫-格拉夫顿-加尔教授宣布退休,享年 92 岁。2020年8月13日,约瑟夫-格拉夫顿-高尔教授的老学员和同事们在网上举行了退休庆祝活动,庆祝约瑟夫-格拉夫顿-高尔教授 "杰出的职业生涯和惊人的发现",内容涵盖了约瑟夫-格拉夫顿-高尔教授近70年的教育和研究生涯。我作为乔的 2000 年代学员代表,发表了题为 "乔的七个定理 "的演讲。2024 年 9 月 12 日,乔老安详辞世,享年 96 岁。在此,我对之前的演讲进行扩充和更新,阐释科学家的科学家约瑟夫-G-加尔的 "七大定理",以示悼念。
{"title":"Seven Theorems of Joseph G. Gall.","authors":"Ji-Long Liu","doi":"10.1016/j.yexcr.2024.114343","DOIUrl":"https://doi.org/10.1016/j.yexcr.2024.114343","url":null,"abstract":"<p><p>On June 30, 2020, Professor Joseph Grafton Gall announced his retirement at 92. On August 13, 2020, Joe's former trainees and colleagues held a retirement celebration online to celebrate Joe's \"Remarkable Career with Astonishing Discoveries\", covering Joe's nearly 70 years of education and research. As a representative of Joe's trainees in the 2000s, I gave a speech titled \"Seven Theorems of Joe\". On September 12, 2024, Joe passed away peacefully, at 96. In memoriam, here I expand and update my previous speech and explain the \"Seven Theorems of Joseph G. Gall\", a scientists' scientist.</p>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":" ","pages":"114343"},"PeriodicalIF":3.3,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knockdown of Leucine-rich alpha-2-glycoprotein 1 alleviates renal ischemia-reperfusion injury by inhibiting NOX4-mediated apoptosis, inflammation, and oxidative stress. 敲除富亮氨酸α-2-糖蛋白1可抑制NOX4介导的细胞凋亡、炎症和氧化应激,从而减轻肾缺血再灌注损伤。
IF 3.3 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2024-11-18 DOI: 10.1016/j.yexcr.2024.114341
Jianfeng Ye, Cheng Qiu, Lexi Zhang

Renal ischemia-reperfusion (I/R) injury leads mainly to acute kidney injury. Leucine-rich alpha-2-glycoprotein 1 (LRG) is upregulated in kidney tissues of mice after renal I/R injury. However, its role in renal I/R injury has not been fully elucidated. A mouse model of renal I/R injury was constructed by unilateral renal pedicle clamping and reperfusion. Mice undergoing I/R procedures exhibited renal function impairment and increased LRG protein expression compared with mice receiving sham operations. Tail vein injection with lentivirus carrying shLRG decreased renal I/R injury-induced increase in caspase-3 activity, IL-1β and IL-18 concentrations, and ROS production. Furthermore, shRNA-mediated LRG knockdown in HK-2 cells protected against H/R-induced cell damage. LRG could upregulate the expression of NADPH oxidase 4 (NOX4). We also determined the increased NOX4 expression in kidney tissues of renal I/R-operated mice and H/R-treated HK-2 cells. NOX4 overexpression reversed the inhibitory role of LRG knockdown in HK-2 cell damage caused by H/R. Collectively, our findings demonstrate that LRG knockdown decreases the NOX4 expression, thereby alleviating renal I/R injury by inhibiting cell apoptosis, inflammation, and oxidative stress.

肾缺血再灌注(I/R)损伤主要导致急性肾损伤。富亮氨酸α-2-糖蛋白 1(LRG)在肾脏 I/R 损伤后的小鼠肾脏组织中上调。然而,它在肾脏 I/R 损伤中的作用尚未完全阐明。通过单侧肾蒂夹闭和再灌注,构建了肾脏I/R损伤小鼠模型。与接受假手术的小鼠相比,接受 I/R 手术的小鼠表现出肾功能损伤和 LRG 蛋白表达增加。尾静脉注射携带 shLRG 的慢病毒可降低肾脏 I/R 损伤引起的 caspase-3 活性、IL-1β 和 IL-18 浓度以及 ROS 生成的增加。此外,shRNA介导的HK-2细胞LRG敲除保护了H/R诱导的细胞损伤。LRG能上调NADPH氧化酶4(NOX4)的表达。我们还检测了肾脏I/R手术小鼠肾组织和H/R处理的HK-2细胞中NOX4表达的增加。NOX4 的过表达逆转了 LRG 敲除对 H/R 引起的 HK-2 细胞损伤的抑制作用。总之,我们的研究结果表明,LRG敲除可降低NOX4的表达,从而通过抑制细胞凋亡、炎症和氧化应激减轻肾脏I/R损伤。
{"title":"Knockdown of Leucine-rich alpha-2-glycoprotein 1 alleviates renal ischemia-reperfusion injury by inhibiting NOX4-mediated apoptosis, inflammation, and oxidative stress.","authors":"Jianfeng Ye, Cheng Qiu, Lexi Zhang","doi":"10.1016/j.yexcr.2024.114341","DOIUrl":"https://doi.org/10.1016/j.yexcr.2024.114341","url":null,"abstract":"<p><p>Renal ischemia-reperfusion (I/R) injury leads mainly to acute kidney injury. Leucine-rich alpha-2-glycoprotein 1 (LRG) is upregulated in kidney tissues of mice after renal I/R injury. However, its role in renal I/R injury has not been fully elucidated. A mouse model of renal I/R injury was constructed by unilateral renal pedicle clamping and reperfusion. Mice undergoing I/R procedures exhibited renal function impairment and increased LRG protein expression compared with mice receiving sham operations. Tail vein injection with lentivirus carrying shLRG decreased renal I/R injury-induced increase in caspase-3 activity, IL-1β and IL-18 concentrations, and ROS production. Furthermore, shRNA-mediated LRG knockdown in HK-2 cells protected against H/R-induced cell damage. LRG could upregulate the expression of NADPH oxidase 4 (NOX4). We also determined the increased NOX4 expression in kidney tissues of renal I/R-operated mice and H/R-treated HK-2 cells. NOX4 overexpression reversed the inhibitory role of LRG knockdown in HK-2 cell damage caused by H/R. Collectively, our findings demonstrate that LRG knockdown decreases the NOX4 expression, thereby alleviating renal I/R injury by inhibiting cell apoptosis, inflammation, and oxidative stress.</p>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":" ","pages":"114341"},"PeriodicalIF":3.3,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142681148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyaluronic acid-modified extracellular vesicles for targeted doxorubicin delivery in hepatocellular carcinoma 透明质酸修饰细胞外囊泡用于肝细胞癌中多柔比星的靶向输送
IF 3.3 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2024-11-16 DOI: 10.1016/j.yexcr.2024.114332
Yue Liu , Benjamin Hinnant , Shang Chen , Hongyan Tao , Ziyu Huang , Meng Qian , Manqian Zhou , Zhibo Han , Zhong-Chao Han , Jun Zhang , Zongjin Li
Hepatocellular carcinoma (HCC), a prevalent and deadly cancer, poses a significant challenge with current treatments due to limitations such as poor stability, off-target effects, and severe side effects. Extracellular vesicles (EVs), derived from tumor cells, have the remarkable ability to home back to their cells of origin and can serve as Trojan horses for drug delivery. CD44, a cell surface glycoprotein, promotes cancer stem cell-like properties and is linked to poor prognosis and resistance to chemotherapy in HCC. Therefore, targeting CD44-expressing HCC cells is of interest in the development of novel therapeutic strategies for the treatment of HCC. In this study, we developed tumor cell-derived EVs (TEVs) functionalized with hyaluronic acid (HA) to serve as natural carriers for the precise delivery of doxorubicin (Dox), which specifically targets HCC cells expressing CD44. Our results demonstrated that HA-engineered EVs (HA-EVs) significantly enhanced Dox accumulation within HCC cells. In a mouse model, HA-EVs effectively delivered Dox to tumors, suppressing their growth and progression while minimizing systemic toxicity. This study demonstrates the potential of HA-functionalized EVs as a novel and targeted therapeutic platform for HCC, offering a valuable strategy for improving drug delivery and patient outcomes. This study presents a promising strategy to advance targeted chemotherapy for HCC and address the challenges associated with conventional treatments. Engineered HA-functionalized EVs offer a tailored and efficient approach to increase drug delivery precision, underscoring their potential as a novel therapeutic platform in the realm of HCC treatment.
肝细胞癌(HCC)是一种常见的致命癌症,由于稳定性差、脱靶效应和严重副作用等局限性,目前的治疗方法面临巨大挑战。源自肿瘤细胞的胞外囊泡(EVs)具有返回原发细胞的超强能力,可以作为药物输送的特洛伊木马。CD44是一种细胞表面糖蛋白,具有类似癌症干细胞的特性,与HCC的不良预后和化疗耐药性有关。因此,靶向表达 CD44 的 HCC 细胞是开发治疗 HCC 的新型治疗策略的兴趣所在。在这项研究中,我们开发了用透明质酸(HA)功能化的肿瘤细胞衍生EVs(TEVs),作为天然载体精确递送多柔比星(Dox),Dox可特异性靶向表达CD44的HCC细胞。我们的研究结果表明,HA-工程化EVs(HA-EVs)能显著增强多柔比星在HCC细胞内的蓄积。在小鼠模型中,HA-EVs 能有效地将 Dox 送入肿瘤,抑制肿瘤的生长和恶化,同时将全身毒性降至最低。这项研究证明了 HA 功能化 EVs 作为新型 HCC 靶向治疗平台的潜力,为改善给药和患者预后提供了宝贵的策略。这项研究为推进HCC的靶向化疗和应对与传统治疗相关的挑战提供了一种前景广阔的策略。工程化的 HA 功能化 EVs 提供了一种量身定制的高效方法来提高给药的精确性,突出了其在 HCC 治疗领域作为新型治疗平台的潜力。
{"title":"Hyaluronic acid-modified extracellular vesicles for targeted doxorubicin delivery in hepatocellular carcinoma","authors":"Yue Liu ,&nbsp;Benjamin Hinnant ,&nbsp;Shang Chen ,&nbsp;Hongyan Tao ,&nbsp;Ziyu Huang ,&nbsp;Meng Qian ,&nbsp;Manqian Zhou ,&nbsp;Zhibo Han ,&nbsp;Zhong-Chao Han ,&nbsp;Jun Zhang ,&nbsp;Zongjin Li","doi":"10.1016/j.yexcr.2024.114332","DOIUrl":"10.1016/j.yexcr.2024.114332","url":null,"abstract":"<div><div>Hepatocellular carcinoma (HCC), a prevalent and deadly cancer, poses a significant challenge with current treatments due to limitations such as poor stability, off-target effects, and severe side effects. Extracellular vesicles (EVs), derived from tumor cells, have the remarkable ability to home back to their cells of origin and can serve as Trojan horses for drug delivery. CD44, a cell surface glycoprotein, promotes cancer stem cell-like properties and is linked to poor prognosis and resistance to chemotherapy in HCC. Therefore, targeting CD44-expressing HCC cells is of interest in the development of novel therapeutic strategies for the treatment of HCC. In this study, we developed tumor cell-derived EVs (TEVs) functionalized with hyaluronic acid (HA) to serve as natural carriers for the precise delivery of doxorubicin (Dox), which specifically targets HCC cells expressing CD44. Our results demonstrated that HA-engineered EVs (HA-EVs) significantly enhanced Dox accumulation within HCC cells. In a mouse model, HA-EVs effectively delivered Dox to tumors, suppressing their growth and progression while minimizing systemic toxicity. This study demonstrates the potential of HA-functionalized EVs as a novel and targeted therapeutic platform for HCC, offering a valuable strategy for improving drug delivery and patient outcomes. This study presents a promising strategy to advance targeted chemotherapy for HCC and address the challenges associated with conventional treatments. Engineered HA-functionalized EVs offer a tailored and efficient approach to increase drug delivery precision, underscoring their potential as a novel therapeutic platform in the realm of HCC treatment.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"443 2","pages":"Article 114332"},"PeriodicalIF":3.3,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142647211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spotlight on the function and trends on Extrachromosomal circular DNA (eccDNA) : A bibliometric analysis from 2008-2023. 聚焦染色体外环状 DNA(eccDNA)的功能和趋势 :2008-2023年文献计量分析。
IF 3.3 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2024-11-13 DOI: 10.1016/j.yexcr.2024.114318
Fan Hu, Zhengqi Qiu

Extrachromosomal circular DNA (eccDNA),a type of circular DNA that has a nucleosomal structure, is widely distributed in eukaryotic chromosomes and has been found to modulate genome instability and plasticity, playing a role in regulating gene expression and genome evolution. To comprehensively outline the stages of eccDNA research development, including author collaborations, research topics and hotspots, and their temporal evolution trends, we conducted a bibliometric analysis of 242 publications related to eccDNA research published from 2008-2023 in the Web of Science Core Collection. The bibliometric analysis was performed using CiteSpace, the R package Bibliometrix, and VOSviewer. The USA, the University of California system, and Turner Km were found to be the most influential nation, organization, and author in this field, respectively. The exploration of Characterization and Diagnosis, Heterochromatin,Circ-Seq and Cancer Drug Resistance on eccDNA are the most concerned hotspots. EccDNA research has become a rapidly growing hotspot, receiving extensive attention from scholars in recent years. This study is the first to investigate the development and current challenges of eccDNA research through bibliometric analysis.The research on eccDNA has advanced from disorder to more intricate molecular functions. At present, the rapid growth of eccDNA studies in cancer has not been accompanied by an intuitive analysis of its evolutionary patterns. This review provides an overview of eccDNA's biological characteristics and functions, with a focus on its role in cancer research.

染色体外环状DNA(eccDNA)是一种具有核糖体结构的环状DNA,广泛分布于真核生物染色体中,被发现可以调节基因组的不稳定性和可塑性,在调控基因表达和基因组进化中发挥作用。为了全面勾勒cccDNA研究的发展阶段,包括作者合作、研究课题和热点及其时间演变趋势,我们对2008-2023年发表在《科学网核心文库》(Web of Science Core Collection)中的242篇与cccDNA研究相关的论文进行了文献计量分析。文献计量分析使用了CiteSpace、R软件包Bibliometrix和VOSviewer。结果发现,美国、加利福尼亚大学系统和特纳-克姆分别是该领域最有影响力的国家、组织和作者。对cccDNA的表征与诊断、异染色质、Circ-Seq和癌症耐药性的探索是最受关注的热点。ccDNA研究已成为一个迅速发展的热点,近年来受到学者们的广泛关注。ccDNA的研究已从无序发展到更为复杂的分子功能。目前,癌症中cccDNA研究的快速发展并未伴随着对其进化模式的直观分析。这篇综述概述了cccDNA的生物学特征和功能,重点介绍了它在癌症研究中的作用。
{"title":"Spotlight on the function and trends on Extrachromosomal circular DNA (eccDNA) : A bibliometric analysis from 2008-2023.","authors":"Fan Hu, Zhengqi Qiu","doi":"10.1016/j.yexcr.2024.114318","DOIUrl":"https://doi.org/10.1016/j.yexcr.2024.114318","url":null,"abstract":"<p><p>Extrachromosomal circular DNA (eccDNA),a type of circular DNA that has a nucleosomal structure, is widely distributed in eukaryotic chromosomes and has been found to modulate genome instability and plasticity, playing a role in regulating gene expression and genome evolution. To comprehensively outline the stages of eccDNA research development, including author collaborations, research topics and hotspots, and their temporal evolution trends, we conducted a bibliometric analysis of 242 publications related to eccDNA research published from 2008-2023 in the Web of Science Core Collection. The bibliometric analysis was performed using CiteSpace, the R package Bibliometrix, and VOSviewer. The USA, the University of California system, and Turner Km were found to be the most influential nation, organization, and author in this field, respectively. The exploration of Characterization and Diagnosis, Heterochromatin,Circ-Seq and Cancer Drug Resistance on eccDNA are the most concerned hotspots. EccDNA research has become a rapidly growing hotspot, receiving extensive attention from scholars in recent years. This study is the first to investigate the development and current challenges of eccDNA research through bibliometric analysis.The research on eccDNA has advanced from disorder to more intricate molecular functions. At present, the rapid growth of eccDNA studies in cancer has not been accompanied by an intuitive analysis of its evolutionary patterns. This review provides an overview of eccDNA's biological characteristics and functions, with a focus on its role in cancer research.</p>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":" ","pages":"114318"},"PeriodicalIF":3.3,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142638435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LOXL1 promotes gastric cancer progression by β-catenin-cyclinD mediated proliferation. LOXL1通过β-catenin-cyclinD介导的增殖促进胃癌进展。
IF 3.3 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2024-11-13 DOI: 10.1016/j.yexcr.2024.114331
Jin-E Liang, Bo-Wen Bao, Xue-Hua He, Wen-Qing Lu, Yang Liu, Jin Wang, Xiu-Juan Qu, Dong-Yang Li, Xiao-Fang Che

Although much progress has been made in chemotherapy or target therapy for advanced gastric cancer, the prognosis is still poor. It is necessary to screen biomarkers for early diagnosis and prognosis prediction. However, the prognostic value of LOX family in gastric cancer and the underlying molecular mechanisms for promoting the progression of gastric cancer remains unclear. Among five members of LOX family, LOXL1 was the unique independent prognostic risk factor. The nomogram established based on the expression of LOXL1 and other clinical parameters could predict the overall survival rate of gastric cancer. Knockdown (KD) of LOXL1 decreased cell proliferation and led to G1 phase arrest in gastric cells. According to GSEA analysis that LOXL1 was positively correlated with the WNT signaling pathway, in vitro experiment proved that LOXL1-KD reduced the phosphorylation level of β-catenin and the expression of the downstream G1 phase checkpoint CCND1. In conclusion, LOXL1 has been identified as a potential risk prognostic biomarker for gastric cancer by promoting gastric cancer proliferation via WNT/β-catenin/cyclinD1 pathway.

尽管晚期胃癌的化疗或靶向治疗取得了很大进展,但预后仍然很差。有必要筛选生物标志物来进行早期诊断和预后预测。然而,LOX 家族在胃癌中的预后价值以及促进胃癌进展的潜在分子机制仍不清楚。在 LOX 家族的五个成员中,LOXL1 是唯一的独立预后风险因子。根据LOXL1的表达和其他临床参数建立的提名图可以预测胃癌的总生存率。敲除(KD)LOXL1可减少胃癌细胞的增殖并导致G1期停滞。根据GSEA分析,LOXL1与WNT信号通路呈正相关,体外实验证明LOXL1-KD降低了β-catenin的磷酸化水平和下游G1期检查点CCND1的表达。
{"title":"LOXL1 promotes gastric cancer progression by β-catenin-cyclinD mediated proliferation.","authors":"Jin-E Liang, Bo-Wen Bao, Xue-Hua He, Wen-Qing Lu, Yang Liu, Jin Wang, Xiu-Juan Qu, Dong-Yang Li, Xiao-Fang Che","doi":"10.1016/j.yexcr.2024.114331","DOIUrl":"10.1016/j.yexcr.2024.114331","url":null,"abstract":"<p><p>Although much progress has been made in chemotherapy or target therapy for advanced gastric cancer, the prognosis is still poor. It is necessary to screen biomarkers for early diagnosis and prognosis prediction. However, the prognostic value of LOX family in gastric cancer and the underlying molecular mechanisms for promoting the progression of gastric cancer remains unclear. Among five members of LOX family, LOXL1 was the unique independent prognostic risk factor. The nomogram established based on the expression of LOXL1 and other clinical parameters could predict the overall survival rate of gastric cancer. Knockdown (KD) of LOXL1 decreased cell proliferation and led to G1 phase arrest in gastric cells. According to GSEA analysis that LOXL1 was positively correlated with the WNT signaling pathway, in vitro experiment proved that LOXL1-KD reduced the phosphorylation level of β-catenin and the expression of the downstream G1 phase checkpoint CCND1. In conclusion, LOXL1 has been identified as a potential risk prognostic biomarker for gastric cancer by promoting gastric cancer proliferation via WNT/β-catenin/cyclinD1 pathway.</p>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":" ","pages":"114331"},"PeriodicalIF":3.3,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142638416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SP1-mediated transcriptional repression of SFRP5 is correlated with cardiac fibroblast activation and atrial myocyte apoptosis in the development of atrial fibrillation SP1 介导的 SFRP5 转录抑制与心房颤动发生过程中心脏成纤维细胞活化和心房肌细胞凋亡有关。
IF 3.3 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2024-11-12 DOI: 10.1016/j.yexcr.2024.114326
Yanyan Sun, Zhenzhen Hu, Jie Han, Gang Li
Secreted frizzled related protein 5 (SFRP5) is a recognized cardioprotective protein with diminished expression in atrial fibrillation (AF). This study investigates SFRP5's function in AF-related cardiac fibrosis and cardiomyocyte apoptosis, exploring the underlying dysregulation causes. Utilizing C57BL/6 mice, mouse cardiac fibroblasts (CFs), and HC-1 mouse atrial myocyte cell line, AF models were induced by angiotensin Ⅱ (Ang Ⅱ). SFRP5 levels were consistently decreased in plasma samples from clinical patients, modeled mice, and CF culture supernatants. Treatment with recombinant SFRP5 restored its levels, mitigating Ang Ⅱ-induced AF in mice and ameliorating atrial tissue fibrosis and oxidative stress. In vitro, SFRP5 recombinant protein suppressed CF activation and fibrosis-related markers. The study identified Sp1 transcription factor (SP1) binding to the SFRP5 promoter, causing transcriptional repression. SP1 knockdown reinstated SFRP5 levels in mice and CFs, thus suppressing fibrosis. Additionally, SP1 knockdown attenuated Ang Ⅱ-induced apoptosis in HC-1 cells, but this effect was counteracted by concurrent SFRP5 knockdown. In conclusion, this investigation underscores that SP1 mediates SFRP5 loss during AF by transcriptional repression, contributing to fibrosis and myocyte apoptosis. These findings illuminate potential therapeutic interventions targeting the SFRP5-SP1 axis in AF-related cardiac complications.
分泌型褐飞虱相关蛋白 5(SFRP5)是一种公认的心脏保护蛋白,但在心房颤动(房颤)中的表达量却减少了。本研究调查了 SFRP5 在心房颤动相关心脏纤维化和心肌细胞凋亡中的功能,探讨了其潜在的失调原因。利用 C57BL/6 小鼠、小鼠心脏成纤维细胞(CFs)和 HC-1 小鼠心房肌细胞系,通过血管紧张素Ⅱ(Ang Ⅱ)诱导房颤模型。临床患者血浆样本、模型小鼠血浆样本和 CF 培养上清液中 SFRP5 的水平持续下降。用重组 SFRP5 治疗可恢复其水平,减轻 Ang Ⅱ 诱导的小鼠房颤,改善心房组织纤维化和氧化应激。在体外,SFRP5 重组蛋白可抑制 CF 活化和纤维化相关标志物。研究发现 Sp1 转录因子(SP1)与 SFRP5 启动子结合,导致转录抑制。SP1敲除可恢复小鼠和CF中的SFRP5水平,从而抑制纤维化。此外,SP1敲除可减轻Ang Ⅱ诱导的HC-1细胞凋亡,但同时敲除SFRP5可抵消这种效应。总之,这项研究强调,SP1 在房颤期间通过转录抑制介导了 SFRP5 的丢失,导致纤维化和肌细胞凋亡。这些发现揭示了针对房颤相关心脏并发症的 SFRP5-SP1 轴的潜在治疗干预措施。
{"title":"SP1-mediated transcriptional repression of SFRP5 is correlated with cardiac fibroblast activation and atrial myocyte apoptosis in the development of atrial fibrillation","authors":"Yanyan Sun,&nbsp;Zhenzhen Hu,&nbsp;Jie Han,&nbsp;Gang Li","doi":"10.1016/j.yexcr.2024.114326","DOIUrl":"10.1016/j.yexcr.2024.114326","url":null,"abstract":"<div><div>Secreted frizzled related protein 5 (SFRP5) is a recognized cardioprotective protein with diminished expression in atrial fibrillation (AF). This study investigates SFRP5's function in AF-related cardiac fibrosis and cardiomyocyte apoptosis, exploring the underlying dysregulation causes. Utilizing C57BL/6 mice, mouse cardiac fibroblasts (CFs), and HC-1 mouse atrial myocyte cell line, AF models were induced by angiotensin Ⅱ (Ang Ⅱ). SFRP5 levels were consistently decreased in plasma samples from clinical patients, modeled mice, and CF culture supernatants. Treatment with recombinant SFRP5 restored its levels, mitigating Ang Ⅱ-induced AF in mice and ameliorating atrial tissue fibrosis and oxidative stress. <em>In vitro</em>, SFRP5 recombinant protein suppressed CF activation and fibrosis-related markers. The study identified Sp1 transcription factor (SP1) binding to the SFRP5 promoter, causing transcriptional repression. SP1 knockdown reinstated SFRP5 levels in mice and CFs, thus suppressing fibrosis. Additionally, SP1 knockdown attenuated Ang Ⅱ-induced apoptosis in HC-1 cells, but this effect was counteracted by concurrent SFRP5 knockdown. In conclusion, this investigation underscores that SP1 mediates SFRP5 loss during AF by transcriptional repression, contributing to fibrosis and myocyte apoptosis. These findings illuminate potential therapeutic interventions targeting the SFRP5-SP1 axis in AF-related cardiac complications.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"443 2","pages":"Article 114326"},"PeriodicalIF":3.3,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
METTL3/YTHDF1 stabilizes CORO6 expression promoting osteosarcoma progression through glycolysis METTL3/YTHDF1通过糖酵解稳定CORO6的表达,促进骨肉瘤的进展。
IF 3.3 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2024-11-12 DOI: 10.1016/j.yexcr.2024.114328
Xuzhou Liu , Wenchong Yu , Wei Song , Zhengqian Zhang , Benqiang Chen , Hongsheng Lin
This study investigates the role of CORO6 (Coronin 6) in the development of osteosarcoma. Osteosarcoma is a common malignant bone tumor in children and adolescents, characterized by rapid and irregular bone growth and a high risk of distant lung metastasis. CORO6 is a member of the Coronin family, known for its conserved WD40 repeat domain. This structure allows CORO6 to inhibit actin dynamics through interactions with F-actin and Arp2/3, thereby affecting the organization of the cytoskeleton. Our research found that in osteosarcoma patients, the levels of CORO6 are significantly elevated. Experimental observations showed that reducing the expression of CORO6 significantly inhibits the growth, migration, and invasion abilities of osteosarcoma cells. Moreover, in vivo experiments demonstrated that the absence of CORO6 effectively inhibits the growth of osteosarcoma in animal models. We also discovered that CORO6 promotes the proliferation, migration and invasion capabilities of osteosarcoma cells by activating the Wnt/β-catenin signaling pathway. Moreover, CORO6 plays a critical important role in glycolysis of osteosarcoma cells. Mechanically, we found that METTL3/YTHDF1 induced m6A modification of CORO6 mRNA promoted the expression of CORO6 by enhancing its stability. These findings offer new directions for the treatment of osteosarcoma, suggesting that CORO6 could be a novel prognostic biomarker and an effective therapeutic target for patients.
In summary, CORO6, as an oncogene, plays a key role in the development of osteosarcoma, providing a crucial theoretical basis for the development of new osteosarcoma treatment strategies.
这项研究探讨了CORO6(冠状病毒蛋白6)在骨肉瘤发病过程中的作用。骨肉瘤是儿童和青少年常见的恶性骨肿瘤,其特点是骨生长迅速且不规则,远处肺转移风险高。CORO6 是 Coronin 家族的成员,因其保守的 WD40 重复结构域而闻名。这种结构使CORO6能够通过与F-肌动蛋白和Arp2/3的相互作用抑制肌动蛋白的动力学,从而影响细胞骨架的组织。我们的研究发现,在骨肉瘤患者中,CORO6 的水平显著升高。实验观察表明,减少 CORO6 的表达可明显抑制骨肉瘤细胞的生长、迁移和侵袭能力。此外,体内实验表明,在动物模型中,CORO6 的缺失可有效抑制骨肉瘤的生长。我们还发现,CORO6 通过激活 Wnt/β-catenin 信号通路促进骨肉瘤细胞的增殖、迁移和侵袭能力。此外,CORO6 在骨肉瘤细胞的糖化过程中发挥着至关重要的作用。在机制上,我们发现 METTL3/YTHDF1 诱导的 CORO6 mRNA m6A 修饰通过增强 CORO6 的稳定性来促进其表达。这些发现为骨肉瘤的治疗提供了新的方向,提示CORO6可能是一种新的预后生物标志物和患者的有效治疗靶点。综上所述,CORO6作为一种癌基因,在骨肉瘤的发生发展中起着关键作用,为制定新的骨肉瘤治疗策略提供了重要的理论依据。
{"title":"METTL3/YTHDF1 stabilizes CORO6 expression promoting osteosarcoma progression through glycolysis","authors":"Xuzhou Liu ,&nbsp;Wenchong Yu ,&nbsp;Wei Song ,&nbsp;Zhengqian Zhang ,&nbsp;Benqiang Chen ,&nbsp;Hongsheng Lin","doi":"10.1016/j.yexcr.2024.114328","DOIUrl":"10.1016/j.yexcr.2024.114328","url":null,"abstract":"<div><div>This study investigates the role of CORO6 (Coronin 6) in the development of osteosarcoma. Osteosarcoma is a common malignant bone tumor in children and adolescents, characterized by rapid and irregular bone growth and a high risk of distant lung metastasis. CORO6 is a member of the Coronin family, known for its conserved WD40 repeat domain. This structure allows CORO6 to inhibit actin dynamics through interactions with F-actin and Arp2/3, thereby affecting the organization of the cytoskeleton. Our research found that in osteosarcoma patients, the levels of CORO6 are significantly elevated. Experimental observations showed that reducing the expression of CORO6 significantly inhibits the growth, migration, and invasion abilities of osteosarcoma cells. Moreover, in vivo experiments demonstrated that the absence of CORO6 effectively inhibits the growth of osteosarcoma in animal models. We also discovered that CORO6 promotes the proliferation, migration and invasion capabilities of osteosarcoma cells by activating the Wnt/β-catenin signaling pathway. Moreover, CORO6 plays a critical important role in glycolysis of osteosarcoma cells. Mechanically, we found that METTL3/YTHDF1 induced m6A modification of CORO6 mRNA promoted the expression of CORO6 by enhancing its stability. These findings offer new directions for the treatment of osteosarcoma, suggesting that CORO6 could be a novel prognostic biomarker and an effective therapeutic target for patients.</div><div>In summary, CORO6, as an oncogene, plays a key role in the development of osteosarcoma, providing a crucial theoretical basis for the development of new osteosarcoma treatment strategies.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"443 2","pages":"Article 114328"},"PeriodicalIF":3.3,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Matrix Gla protein suppresses osteoblast senescence and promotes osteogenic differentiation by the PI3K-AKT signaling pathway. 基质 Gla 蛋白通过 PI3K-AKT 信号通路抑制成骨细胞衰老并促进成骨细胞分化。
IF 3.3 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2024-11-11 DOI: 10.1016/j.yexcr.2024.114329
Min Zhang, Sha Liu, Yulin Chen, Yifa Chen, Jiaojiao He, Yuting Xia, Ya Yang

Age-related bone loss in mice is associated with senescent cell accumulation and reduced bone formation by osteoblasts. Matrix Gla protein (MGP), secreted by osteoblasts, is pivotal in regulating the bone extracellular matrix mineralization. Previous research has demonstrated that Mgp null mice exhibit osteopenia and fractures, and ultimately die prematurely. To elucidate the mechanisms underlying MGP's role of MGP in bone metabolism, we generated osteoblast-specific Mgp knockout (Mgp cKO) mice by crossing Mgpfl/fl mice with Bglap-Cre mice. The study revealed that in 3-month-old Mgp cKO male mice, trabecular bone volume decreased, and the senescence marker protein p21 increased. Primary osteoblasts from Mgp cKO mice exhibited markers of DNA damage and senescence, such as increased γH2AX foci, p21, and senescence-associated β-galactosidase staining, as well as attenuated cellular proliferation and osteogenic differentiation abilities. In addition, bone marrow stromal cells' colony formation and spontaneous osteogenic ability were impaired in Mgp cKO mice, whereas osteoclastogenesis was enhanced. In vitro treatment with recombinant human MGP promotes osteogenesis in osteoblasts derived from Mgp cKO mice via the PI3K-AKT signaling pathway. Thus, our results suggest that MGP is protective by suppressing osteoblast senescence, offering new insights into potential therapeutic strategies for age-related osteoporosis.

小鼠与年龄相关的骨质流失与衰老细胞积累和成骨细胞骨形成减少有关。成骨细胞分泌的基质Gla蛋白(MGP)在调节骨细胞外基质矿化过程中起着关键作用。先前的研究表明,Mgp 缺失的小鼠会出现骨质增生和骨折,并最终过早死亡。为了阐明MGP在骨代谢中的作用机制,我们通过将Mgpfl/fl小鼠与Bglap-Cre小鼠杂交,产生了成骨细胞特异性Mgp基因敲除(Mgp cKO)小鼠。研究发现,3 个月大的 Mgp cKO 雄性小鼠骨小梁体积减少,衰老标志蛋白 p21 增加。Mgp cKO小鼠的原代成骨细胞表现出DNA损伤和衰老的标志物,如γH2AX病灶、p21和衰老相关的β-半乳糖苷酶染色增加,细胞增殖和成骨分化能力减弱。此外,Mgp cKO 小鼠骨髓基质细胞的集落形成和自发性成骨能力受损,而破骨细胞生成能力增强。体外处理重组人MGP可通过PI3K-AKT信号通路促进Mgp cKO小鼠成骨细胞的成骨。因此,我们的研究结果表明,MGP 通过抑制成骨细胞的衰老起到保护作用,为老年性骨质疏松症的潜在治疗策略提供了新的思路。
{"title":"Matrix Gla protein suppresses osteoblast senescence and promotes osteogenic differentiation by the PI3K-AKT signaling pathway.","authors":"Min Zhang, Sha Liu, Yulin Chen, Yifa Chen, Jiaojiao He, Yuting Xia, Ya Yang","doi":"10.1016/j.yexcr.2024.114329","DOIUrl":"https://doi.org/10.1016/j.yexcr.2024.114329","url":null,"abstract":"<p><p>Age-related bone loss in mice is associated with senescent cell accumulation and reduced bone formation by osteoblasts. Matrix Gla protein (MGP), secreted by osteoblasts, is pivotal in regulating the bone extracellular matrix mineralization. Previous research has demonstrated that Mgp null mice exhibit osteopenia and fractures, and ultimately die prematurely. To elucidate the mechanisms underlying MGP's role of MGP in bone metabolism, we generated osteoblast-specific Mgp knockout (Mgp cKO) mice by crossing Mgp<sup>fl/fl</sup> mice with Bglap-Cre mice. The study revealed that in 3-month-old Mgp cKO male mice, trabecular bone volume decreased, and the senescence marker protein p21 increased. Primary osteoblasts from Mgp cKO mice exhibited markers of DNA damage and senescence, such as increased γH2AX foci, p21, and senescence-associated β-galactosidase staining, as well as attenuated cellular proliferation and osteogenic differentiation abilities. In addition, bone marrow stromal cells' colony formation and spontaneous osteogenic ability were impaired in Mgp cKO mice, whereas osteoclastogenesis was enhanced. In vitro treatment with recombinant human MGP promotes osteogenesis in osteoblasts derived from Mgp cKO mice via the PI3K-AKT signaling pathway. Thus, our results suggest that MGP is protective by suppressing osteoblast senescence, offering new insights into potential therapeutic strategies for age-related osteoporosis.</p>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":" ","pages":"114329"},"PeriodicalIF":3.3,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exosomes derived from diabetic microenvironment-preconditioned mesenchymal stem cells ameliorate nonalcoholic fatty liver disease and inhibit pyroptosis of hepatocytes 从糖尿病微环境预处理间充质干细胞中提取的外泌体可改善非酒精性脂肪肝并抑制肝细胞的嗜热性。
IF 3.3 3区 生物学 Q3 CELL BIOLOGY Pub Date : 2024-11-07 DOI: 10.1016/j.yexcr.2024.114325
Anning Wang , Bing Li , Wanlu Su , HaiXia Zhang , Ruofan Hu , Yue Zhang , Jian Zhao , Rui Ren , Yiming Mu , Yu Cheng , Zhaohui Lyu

Aim

Pyroptosis, a type of programmed cell death, is a key mechanism underlying non-alcoholic fatty liver disease (NAFLD). Mesenchymal stem cell (MSC)-derived exosomes (MSC-Exos) have the potential to ameliorate NAFLD, an effect that is enhanced by curcumin preconditioning. We previously reported that diabetic microenvironment preconditioning enhances the secretion capacity and anti-inflammatory activity of MSCs. Therefore, we hypothesized that MSC-Exos would inhibit hepatocyte pyroptosis and thereby ameliorate NAFLD, and that diabetic microenvironment preconditioning would enhance these effects.

Methods

MSCs were preconditioned in a diabetic microenvironment (pMSCs). MSC-Exos and pMSC-Exos collected from MSCs or pMSCs were applied to methionine- and choline-deficient (MCD)-induced NAFLD mice and in vitro models involving induction with lipopolysaccharide or palmitic acid to mimic hepatic steatosis and injury. MCC950 treatment was used as a positive control. We analyzed the characteristics of NAFLD and pyroptosis markers. Protein profiles of MSC-Exos and pMSC-Exos were evaluated by label-free quantitative proteomics.

Results

In vivo, MSC-Exos partially attenuated inflammation and fibrosis, but not lipid deposition and NAFLD progression in the livers of NAFLD mice. pMSC-Exos significantly improved lipid metabolism, hepatic steatosis, inflammation, and fibrosis but also retarded the progression of NAFLD. Pyroptosis was upregulated in the liver of NAFLD mice. MSC-Exos and pMSC-Exos inhibited pyroptosis, and the effect of the latter was greater than that of the former. In vitro, MSC-Exos and pMSC-Exos ameliorated hepatocyte steatosis, lipid metabolism disorder, and inflammation, and pMSC-Exos exerted a greater inhibitory effect on hepatocyte pyroptosis than MSC-Exos did, which were remitted after inhibition of peroxiredoxin-1 (PRDX-1).

Conclusion

MSC-Exos ameliorated NAFLD and inhibited hepatocyte pyroptosis by downregulating the NLRP3/Caspase-1/GSDMD pathway, effects enhanced by pMSC-Exos, partly due to PRDX-1 upregulation.
目的:热核变性是一种程序性细胞死亡,是非酒精性脂肪肝(NAFLD)的一个关键机制。间充质干细胞(MSC)衍生的外泌体(MSC-Exos)具有改善非酒精性脂肪肝的潜力,姜黄素预处理可增强这种效果。我们曾报道,糖尿病微环境预处理可增强间充质干细胞的分泌能力和抗炎活性。因此,我们假设间充质干细胞-Exos能抑制肝细胞脓毒症,从而改善非酒精性脂肪肝,而糖尿病微环境预处理能增强这些效果:方法:间充质干细胞在糖尿病微环境(pMSCs)中进行预处理。方法:在糖尿病微环境(pMSCs)中对间充质干细胞进行预处理。将从间充质干细胞或pMSCs中收集的间充质干细胞-Exos和pMSC-Exos应用于蛋氨酸和胆碱缺乏(MCD)诱导的非酒精性脂肪肝小鼠和体外模型,这些模型涉及用脂多糖或棕榈酸诱导以模拟肝脏脂肪变性和损伤。MCC950 处理被用作阳性对照。我们分析了非酒精性脂肪肝的特征和脂肪变性标志物。通过无标记定量蛋白质组学评估了MSC-Exos和pMSC-Exos的蛋白质谱:在体内,间充质干细胞-Exos能部分减轻非酒精性脂肪肝小鼠肝脏的炎症和纤维化,但不能减轻脂质沉积和非酒精性脂肪肝的进展。非酒精性脂肪肝小鼠肝脏中的裂解酶上调。间充质干细胞-Exos和pMSC-Exos可抑制非酒精性脂肪肝小鼠肝脏的裂解,且后者的作用大于前者。在体外,间充质干细胞-Exos和pMSC-Exos能改善肝细胞脂肪变性、脂质代谢紊乱和炎症,pMSC-Exos对肝细胞脓毒症的抑制作用比间充质干细胞-Exos更大,在抑制过氧化物歧化酶-1(PRDX-1)后,肝细胞脓毒症得到缓解:结论:间充质干细胞-Exos可通过下调NLRP3/Caspase-1/GSDMD通路改善非酒精性脂肪肝并抑制肝细胞脓毒症。
{"title":"Exosomes derived from diabetic microenvironment-preconditioned mesenchymal stem cells ameliorate nonalcoholic fatty liver disease and inhibit pyroptosis of hepatocytes","authors":"Anning Wang ,&nbsp;Bing Li ,&nbsp;Wanlu Su ,&nbsp;HaiXia Zhang ,&nbsp;Ruofan Hu ,&nbsp;Yue Zhang ,&nbsp;Jian Zhao ,&nbsp;Rui Ren ,&nbsp;Yiming Mu ,&nbsp;Yu Cheng ,&nbsp;Zhaohui Lyu","doi":"10.1016/j.yexcr.2024.114325","DOIUrl":"10.1016/j.yexcr.2024.114325","url":null,"abstract":"<div><h3>Aim</h3><div>Pyroptosis, a type of programmed cell death, is a key mechanism underlying non-alcoholic fatty liver disease (NAFLD). Mesenchymal stem cell (MSC)-derived exosomes (MSC-Exos) have the potential to ameliorate NAFLD, an effect that is enhanced by curcumin preconditioning. We previously reported that diabetic microenvironment preconditioning enhances the secretion capacity and anti-inflammatory activity of MSCs. Therefore, we hypothesized that MSC-Exos would inhibit hepatocyte pyroptosis and thereby ameliorate NAFLD, and that diabetic microenvironment preconditioning would enhance these effects.</div></div><div><h3>Methods</h3><div>MSCs were preconditioned in a diabetic microenvironment (pMSCs). MSC-Exos and pMSC-Exos collected from MSCs or pMSCs were applied to methionine- and choline-deficient (MCD)-induced NAFLD mice and <em>in vitro</em> models involving induction with lipopolysaccharide or palmitic acid to mimic hepatic steatosis and injury. MCC950 treatment was used as a positive control. We analyzed the characteristics of NAFLD and pyroptosis markers. Protein profiles of MSC-Exos and pMSC-Exos were evaluated by label-free quantitative proteomics.</div></div><div><h3>Results</h3><div><em>In vivo</em>, MSC-Exos partially attenuated inflammation and fibrosis, but not lipid deposition and NAFLD progression in the livers of NAFLD mice. pMSC-Exos significantly improved lipid metabolism, hepatic steatosis, inflammation, and fibrosis but also retarded the progression of NAFLD. Pyroptosis was upregulated in the liver of NAFLD mice. MSC-Exos and pMSC-Exos inhibited pyroptosis, and the effect of the latter was greater than that of the former. <em>In vitro</em>, MSC-Exos and pMSC-Exos ameliorated hepatocyte steatosis, lipid metabolism disorder, and inflammation, and pMSC-Exos exerted a greater inhibitory effect on hepatocyte pyroptosis than MSC-Exos did, which were remitted after inhibition of peroxiredoxin-1 (PRDX-1).</div></div><div><h3>Conclusion</h3><div>MSC-Exos ameliorated NAFLD and inhibited hepatocyte pyroptosis by downregulating the NLRP3/Caspase-1/GSDMD pathway, effects enhanced by pMSC-Exos, partly due to PRDX-1 upregulation.</div></div>","PeriodicalId":12227,"journal":{"name":"Experimental cell research","volume":"443 2","pages":"Article 114325"},"PeriodicalIF":3.3,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142617390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Experimental cell research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1